CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications

M Liu, S Guo, JM Hibbert, V Jain, N Singh… - Cytokine & growth factor …, 2011 - Elsevier
C–X–C motif chemokine 10 (CXCL10) also known as interferon γ-induced protein 10kDa (IP-
10) or small-inducible cytokine B10 is a cytokine belonging to the CXC chemokine family …

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment

AK Coussens, RJ Wilkinson, Y Hanifa… - Proceedings of the …, 2012 - National Acad Sciences
Calcidiol, the major circulating metabolite of vitamin D, supports induction of pleiotropic
antimicrobial responses in vitro. Vitamin D supplementation elevates circulating calcidiol …

Advances in the diagnosis of tuberculosis

C Lange, T Mori - Respirology, 2010 - Wiley Online Library
Tuberculosis ranges among the leading causes of morbidity and mortality worldwide. A
diagnostic approach to a patient with possible tuberculosis includes a detailed medical …

IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

M Ruhwald, MG Aabye, P Ravn - Expert review of molecular …, 2012 - Taylor & Francis
The current state-of-the-art tests for infection with Mycobacterium tuberculosis–the IFN-γ
release assays–rely on accurate measurement of the cytokine IFN-γ. Many other potential …

Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis

M Tebruegge, B Dutta, S Donath, N Ritz… - American journal of …, 2015 - atsjournals.org
Rationale: Current immunodiagnostic tests for tuberculosis (TB), including the tuberculin
skin test and IFN-γ release assay (IGRA), have significant limitations, which include their …

Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report

NN Chegou, GF Black, M Kidd, PD Van Helden… - BMC pulmonary …, 2009 - Springer
Background Interferon gamma release assays, including the QuantiFERON® TB Gold In
Tube (QFT) have been shown to be accurate in diagnosing Mycobacterium tuberculosis …

Discriminating between latent and active tuberculosis with multiple biomarker responses

M Frahm, ND Goswami, K Owzar, E Hecker, A Mosher… - Tuberculosis, 2011 - Elsevier
We sought to identify biomarker responses to tuberculosis specific antigens which could 1)
improve the diagnosis of tuberculosis infection and 2) allow the differentiation of active and …

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis

M Ruhwald, J Dominguez, I Latorre, M Losi, L Richeldi… - Tuberculosis, 2011 - Elsevier
IP-10 has potential as a diagnostic marker for infection with Mycobacteriumtuberculosis, with
comparable accuracy to QuantiFERON-TB Gold In-Tube test (QFT-IT). The aims were to …

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNγ?

E Whittaker, A Gordon, B Kampmann - PloS one, 2008 - journals.plos.org
Background The blood based interferon-gamma release assays (IGRA) for the diagnosis of
tuberculosis do not discriminate between active TB disease and latent TB infection (LTBI) …

[引用][C] The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement

D Bumbacea, SM Arend, F Eyuboglu… - European …, 2012 - Eur Respiratory Soc